International Edition
Latest News
Health

Gecp Launches Campaign to Change Lung Cáncer Patient Questions

Lung cancer claims more lives in Spain than any other malignancy, with the Sociedad Española de Oncología Médica (SEOM) estimating 34,908 new cases for 2026. The disease accounts for over 23,000 deaths annually, according to figures reported by…

Gecp Launches Campaign to Change Lung Cáncer Patient Questions

Lung cancer claims more lives in Spain than any other malignancy, with the Sociedad Española de Oncología Médica (SEOM) estimating 34,908 new cases for 2026.

The disease accounts for over 23,000 deaths annually, according to figures reported by EFE Health, while displaying rising incidence rates among women and individuals under the age of 50.

While tobacco use remains the primary risk factor responsible for approximately 80% of all diagnoses, about 20% of patients develop the disease without any history of smoking.

“We need to stop asking patients why they developed the disease and start asking ourselves what we are doing to improve their chances.” said Paula Espinosa, spokesperson for the Spanish Lung Cancer Group (GECP) and oncologist at the General Hospital of Valencia, as reported by EFE Health.

Challenging the stigma of non-smoking patients

Patients who never smoked frequently face intrusive questions regarding their lifestyle habits, compounding the emotional toll of a late-stage diagnosis. Inma Escriche, a 55-year-old resident of Valdemoro in Madrid, received her metastatic lung cancer diagnosis in October 2016 despite never smoking and having no family history of the illness.

“I felt questioned and judged. And when they asked me, I would immediately reply: I have lung cancer even though I’m not a smoker.” Escriche told EFE Health. Genetic testing later revealed her tumor stemmed from an alteration in the ROS-1 gene, independent of tobacco exposure.

Gecp Launches Campaign to Change Lung Cáncer Patient Questions
Photo: El Mundo

To combat these societal misconceptions, the GECP launched the “Let’s change the question” campaign ahead of World Lung Cancer Day.

Advances in molecular diagnosis and surgical treatment

Pilar Garrido López, head of medical oncology at the Hospital Ramón y Cajal in Madrid, said that molecular diagnostics and targeted genetic sequencing allow pathologists to characterize tumors precisely and guide personalized treatment decisions, according to coverage by The World.

Miguel Congregado, president of the Sociedad Española de Cirugía Torácica (SECT), said that identifying tumors in early stages via low-dose computed tomography screening offers genuine opportunities for curative surgery, as detailed by infosalus. Meanwhile, recent clinical trials involving chemoimmunotherapy have expanded surgical eligibility for locally advanced cases previously considered inoperable.

Gecp Launches Campaign to Change Lung Cáncer Patient Questions
Photo: Redacción Médica

Funding disparities and future challenges

Bartomeu Massuti, secretary of the GECP and head of oncology at the Hospital Doctor Balmis in Alicante, pointed out that 70% of patients receive their diagnosis at an advanced stage, while public research funding for the disease hovers at a meager 4%.

Disparities in molecular testing access also remain between major university hospitals equipped with next-generation sequencing and smaller regional facilities.

Frequently asked questions

What percentage of lung cancer cases occur in non-smokers?

Approximately 20% of lung cancer diagnoses occur in individuals who have never smoked, often driven by genetic mutations such as ROS-1, EGFR, or ALK alterations.

How many new lung cancer cases are projected for Spain?

The SEOM report estimates 34,908 new lung cancer cases in Spain, comprising 23,079 diagnoses in men and 11,829 in women.

What is the primary goal of the Cambiemos la pregunta campaign?

Launched by the GECP, the campaign aims to eliminate the social stigma and patient guilt associated with lung cancer by redirecting public focus toward research funding, early detection, and innovation access.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”